Determination of prostaglandin E1 and its main plasma metabolites 15-keto-prostaglandin E0 and prostaglandin E0 by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometry

This publication has 12 references indexed in Scilit:

• Effects of Prostaglandin E1 on Oxygen Delivery and Consumption in Patients with the Adult Respiratory Distress Syndrome
  Chest, 1990
• Prostaglandins and extracorporeal circulation
  Prostaglandins, Leukotrienes & Essential Fatty Acids, 1990
• Beneficial effect of long-term PGE1-treatment in left ventricular heart failure
  Prostaglandins, Leukotrienes & Essential Fatty Acids, 1989
• Tritium-labelling of natural and modified prostaglandins
  Journal of Labelled Compounds and Radiopharmaceuticals, 1989
• Prostaglandin E₁in the Adult Respiratory Distress Syndrome: Benefit for Pulmonary Hypertension and Cost for Pulmonary Gas Exchange
  American Review of Respiratory Disease, 1989
• The therapeutic value of vasodilator prostaglandins in multiple organ failure associated with sepsis
  Intensive Care Medicine, 1988
• Estimated rate of thromboxane secretion into the circulation of normal humans.
  Journal of Clinical Investigation, 1986
• Simultaneous determination of prostanoids in plasma by gas chromatograp—negative-ion chemical-ionization mass spectrometry
  Journal of Chromatography B: Biomedical Sciences and Applications, 1985
• INTRAVENOUS PROSTAGLANDIN E1 IN SEVERE PERIPHERAL VASCULAR DISEASE
  The Lancet, 1976
• The Biological Activities of Three Metabolites of Prostaglandin E₁
  Acta Physiologica Scandinavica, 1966